Literature DB >> 35069031

Staging Pouch Surgery in Ulcerative Colitis in the Biological Era.

Anton Risto1, Maie Abdalla2, Pär Myrelid1.   

Abstract

Restorative proctocolectomy, or ileal pouch anal anastomosis, is considered the standard treatment for intractable ulcerative colitis. When the pelvic pouch was first introduced in 1978, a two-stage procedure with proctocolectomy, construction of the pelvic pouch, and a diverting loop with subsequent closure were suggested. Over the decades that the pelvic pouch has been around, some principal technical issues have been addressed to improve the method. In more recent days the laparoscopic approach has been additionally introduced. During the same time-period the medical arsenal has developed far more with the increasing use of immune modulators and the introduction of biologicals. Staging of restorative proctocolectomy with a pelvic pouch refers to how many sessions, or stages, the procedure should be divided into. The main goal with restorative proctocolectomy is a safe operation with optimal short- and long-term function. In this paper we aim to review the present knowledge and views on staging of the pouch procedure in ulcerative colitis, especially with consideration to the treatment with biologicals. Thieme. All rights reserved.

Entities:  

Keywords:  biological therapy; immunomodulators; surgery; ulcerative colitis

Year:  2022        PMID: 35069031      PMCID: PMC8763463          DOI: 10.1055/s-0041-1740039

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  81 in total

1.  Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic Patients.

Authors:  Philip H Sossenheimer; Laura R Glick; Abraham H Dachman; Kinga B Skowron; Michele A Rubin; Konstantin Umanskiy; Radhika Smith; Lisa M Cannon; Roger D Hurst; Russell D Cohen; Neil H Hyman; David T Rubin
Journal:  Dis Colon Rectum       Date:  2019-04       Impact factor: 4.585

2.  Small molecule drugs in the treatment of inflammatory bowel diseases: which one, when and why? - a systematic review.

Authors:  Laura A Lucaciu; Radu Seicean; Andrada Seicean
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-06       Impact factor: 2.566

3.  Preoperative pelvic radiation increases the risk for ileal pouch failure in patients with colitis-associated colorectal cancer.

Authors:  Xian-rui Wu; Ravi P Kiran; Feza H Remzi; Seymour Katz; Saurabh Mukewar; Bo Shen
Journal:  J Crohns Colitis       Date:  2013-02-27       Impact factor: 9.071

4.  Repeat pouch surgery by the abdominal approach safely salvages failed ileal pelvic pouch.

Authors:  Feza H Remzi; Victor W Fazio; Hasan T Kirat; James S Wu; Ian C Lavery; Ravi P Kiran
Journal:  Dis Colon Rectum       Date:  2009-02       Impact factor: 4.585

5.  Transabdominal Redo Ileal Pouch Surgery for Failed Restorative Proctocolectomy: Lessons Learned Over 500 Patients.

Authors:  Feza H Remzi; Erman Aytac; Jean Ashburn; Jinyu Gu; Tracy L Hull; David W Dietz; Luca Stocchi; James M Church; Bo Shen
Journal:  Ann Surg       Date:  2015-10       Impact factor: 12.969

6.  Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study.

Authors:  Laurent Peyrin-Biroulet; Cécile Laclotte; Xavier Roblin; Marc-André Bigard
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

7.  Delayed Ileal Pouch Anal Anastomosis Has a Lower 30-Day Adverse Event Rate: Analysis From the National Surgical Quality Improvement Program.

Authors:  Bharati Kochar; Edward L Barnes; Anne F Peery; Katherine S Cools; Joseph Galanko; Mark Koruda; Hans H Herfarth
Journal:  Inflamm Bowel Dis       Date:  2018-07-12       Impact factor: 5.325

8.  Postoperative Steroid Taper Is Associated With Pelvic Sepsis After Ileal Pouch-anal Anastomosis.

Authors:  Kaitlin A Ritter; John P Burke; Luca Stocchi; Alexandra Aiello; Stefan Holubar; Jean H Ashburn; Jeremy M Lipman; Sherief Shawki; Tracy Hull
Journal:  Inflamm Bowel Dis       Date:  2019-07-17       Impact factor: 5.325

Review 9.  Vedolizumab for the treatment of ulcerative colitis.

Authors:  Andreas Stallmach; Carsten Schmidt; Niels Teich
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-12-15       Impact factor: 3.869

Review 10.  Golimumab for the treatment of ulcerative colitis.

Authors:  Mathurin Flamant; Stephane Paul; Xavier Roblin
Journal:  Expert Opin Biol Ther       Date:  2017-05-16       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.